Active, not recruitingPhase 2NCT04505501

Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Thai Red Cross AIDS Research Centre
Principal Investigator
Sandhya C Vasan, MD PhD
Henry M. Jackson Foundation for the Advancement of Military Medicine
Intervention
N-803(drug)
Enrollment
14 target
Eligibility
18 years · All sexes
Timeline
2021 – 2025

Study locations (1)

Collaborators

Henry M. Jackson Foundation for the Advancement of Military Medicine · Walter Reed Army Institute of Research (WRAIR)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04505501 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency →

← Back to all trials